Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARGET: Glycemic control and symptomatic hypoglycemia in insulin-naïve type 2 diabetes patients treated with insulin glargine or insulin detemir
2006-000324-13Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Insulin glargine (Lantus) with Insulin detemir (Levemir) (2 arms). Primary endpoint: Primary composite endpoint. Started Jul 2006; status: completed.
02
Drugs
insulin glargineinsulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-000324-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000324-13.